Abstract
Parkinson’s disease (PD) is named after the English physician James Parkinson who published the first detailed description of the disorder in the modern Western world. In 1817, Parkinson wrote his “Essay on the Shaking Palsy,” a short monograph which described the features of this disorder. Remarkably, of the six patients he described in his monograph, Parkinson treated only one of these individuals; the remaining five cases were individuals he had simply observed on the streets of his home town of London. Nevertheless, his keen eye noted many of the symptoms which are still considered to be the cardinal characteristics of the disorder he called the “shaking palsy.” In honor of this description, the disease was later named after Parkinson, a term first used by the famous French physician Charcot in the 1880s. Today, PD is the second most common neurodegenerative disease with an estimated five million cases worldwide, although with the aging of the world’s population, the number of individuals with PD in the world is estimated to double by 2030. Thus, this disorder remains as much as a challenge in the twenty-first century as it was when James Parkinson first wrote about it.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316–329
Foley PB (2003) Beans, roots and leaves. A history of the chemical therapy of Parkinsonism. Tectum, Marburg
Halliday GM, Barker RA, Rowe DB (eds) (2011) Non-dopamine lesions in Parkinson’s disease. Oxford University Press, New York
Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E (2011) Priorities in Parkinson’s disease research. Nat Rev Drug Discov 10:377–393
Olanow CW et al (2009) A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med 361:1268–1278
Rascol O, Lozano A, Stern M, Poewe W (2011) Milestones in Parkinson’s disease therapeutics. Mov Disord 26:1072–1082
Wakeman DR, Dodiya HB, Kordower JH (2011) Cell transplantation and gene therapy in Parkinson’s disease. Mt Sinai J Med 78:126–158
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Science+Business Media, LLC, part of Springer Nature
About this entry
Cite this entry
Double, K., Finberg, J. (2022). Parkinson’s Disease. In: Pfaff, D.W., Volkow, N.D., Rubenstein, J.L. (eds) Neuroscience in the 21st Century. Springer, Cham. https://doi.org/10.1007/978-3-030-88832-9_112
Download citation
DOI: https://doi.org/10.1007/978-3-030-88832-9_112
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-88831-2
Online ISBN: 978-3-030-88832-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences